Skip to search formSkip to main contentSkip to account menu

SB 204070A

Known as: 1,4-Benzodioxin-5-carboxylic acid, 8-amino-7-chloro-2,3-dihydro-, (1-butyl-4-piperidinyl)methyl ester, monohydrochloride, SB-204070, SB 204070 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Abstract  5‐Hydroxytryptamine (5‐HT4) receptor agonists increase gastrointestinal (GI) motility by enhancing enteric… 
Highly Cited
2006
Highly Cited
2006
Abstract  Previous studies have demonstrated mixed inhibitory and facilitatory effects of 5‐hydroxytryptamine‐4 (5‐HT4) receptor… 
Highly Cited
2004
Highly Cited
2004
In previous studies, we have found that 5-hydroxytryptamine (5-HT) is a potent stimulant of duodenal mucosal bicarbonate… 
2003
2003
The study was undertaken to investigate the 5‐HT receptor mediating the inhibitory effect of 5‐HT on peristalsis in the guinea… 
2003
2003
We attempted to identify compounds that are effective in blocking the serotonin (5-hydroxytryptamine, 5-HT) receptor(s) that… 
2001
2001
Few previous studies have discussed the changes in serotonin receptor activity in the small intestine of diabetic animals… 
Highly Cited
1996
Highly Cited
1996
The roles of 5-hydroxytryptamine3 (5-HT3), 5-HT4, and nicotinic receptors in the peristaltic reflex were investigated in isolated… 
1995
1995
The ability of 5‐hydroxytryptamine (5‐HT) to evoke contractile activity in the gastric Heidenhain pouch was measured in conscious… 
Highly Cited
1994
Highly Cited
1994
1 The pharmacology of a novel 5‐HT4 receptor antagonist, SB 204070 has been evaluated in the guinea‐pig isolated distal colon…